Evolution and Management of ARDS

This chapter delves into the evolution of ARDS definitions, discussing how COVID-19 cases have prompted a reevaluation. It explores ARDS criteria, management challenges, trial designs, and the potential for precision medicine. The speakers also touch on the distinctions between ARDS states, fibrotic ARDS, and advancements in clinical classification using biomarkers.